Regulation of microRNA using promising dietary phytochemicals: Possible preventive and treatment option of malignant mesothelioma - 16/09/17
pages | 28 |
Iconographies | 6 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Malignant mesothelioma (MM) is a very aggressive, lethal cancer, and its incidence is increasing worldwide. Development of multi-drug resistance, therapy related side-effects, and disease recurrence after therapy are the major problems for the successful treatment of MM. Emerging evidence indicates that dietary phytochemicals can exert anti-cancer activities by regulating microRNA expression. Until now, only one dietary phytochemical (ursolic acid) has been reported to have MM microRNA regulatory ability. A large number of dietary phytochemicals still remain to be tested. In this paper, we have introduced some dietary phytochemicals (curcumin, epigallocatechin gallate, quercetin, genistein, pterostilbene, resveratrol, capsaicin, ellagic acid, benzyl isothiocyanate, phenethyl isothiocyanate, sulforaphane, indole-3-carbinol, 3,3′-diindolylmethane, diallyl disulphide, betulinic acid, and oleanolic acid) which have shown microRNA regulatory activities in various cancers and could regulate MM microRNAs. In addition to microRNA regulatory activities, curcumin, epigallocatechin gallate, quercetin, genistein, resveratrol, phenethyl isothiocyanate, and sulforaphane have anti-mesothelioma potentials, and pterostilbene, capsaicin, ellagic acid, benzyl isothiocyanate, indole-3-carbinol, 3,3′-diindolylmethane, diallyl disulphide, betulinic acid, and oleanolic acid have potentials to inhibit cancer by regulating the expression of various genes which are also known to be aberrant in MM.
Le texte complet de cet article est disponible en PDF.Abbreviations : AKT, Bcl-2, BDNF, BCL2L11, BTG2, BAP1, Bax, Bcl-X, bFGF, CDH1, CDK1/2/4/6, CDKN1A/2A/1B/2B/1C/2C, CDC2/6/20/37/42, Chk1/2, DNMT1/3/3A, EGFL7, EGF, FOXO1/3/M1/3a, FZDA, flt-1/4, HGF, IL-18, IGF-I, IRS-1/2, LATS2, KCNMA1, KDR, MCL-1, MMP-1/2/3/7/9/26, MAPK, NF2, OCT4, pRb, PPP6C, PDGFA/B/β, PTEN, PI3K, PUMA, RB1, RUNX1, STMN1, SRSF2, SMAD2/4, TGF-β, TAM, TYMS, TIMP1/2, VEGF, VEGFRs, XIAP, YWHAZ, ZEB1/2
Keywords : Dietary phytochemicals, Malignant mesothelioma, MicroRNA, Expression, In vitro, In vivo
Plan
Vol 94
P. 1197-1224 - octobre 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?